Alliance Global Partners Maintains Buy on Aspira Womens Health, Lowers Price Target to $5.5
Alliance Global Partners Maintains Buy on Aspira Womens Health, Lowers Price Target to $5.5
Alliance global partners認爲 Aspira Womens Health 值得買入,但下調目標股價至$5.5。
Alliance Global Partners analyst Ben Haynor maintains Aspira Womens Health (NASDAQ:AWH) with a Buy and lowers the price target from $7 to $5.5.
全球合夥人分析師本·海納保持對Aspira Womens Health(納斯達克:AWH)的買入並將目標價從7美元降至5.5美元。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。